Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113711514 | 11371151 | 4 | F | 2012 | 20160826 | 20150812 | 20160906 | EXP | US-PFIZER INC-2015256015 | PFIZER | 62.00 | YR | M | Y | 115.20000 | KG | 20160906 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113711514 | 11371151 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 20 OR 25 MG, CYCLIC (21 DAYS ON 14 DAYS OFF) | Y | 21938 | CAPSULE, HARD | ||||||||
113711514 | 11371151 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, UNK | 0 | 40 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
113711514 | 11371151 | 1 | Renal cell carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
113711514 | 11371151 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
113711514 | 11371151 | Cough | |
113711514 | 11371151 | Dehydration | |
113711514 | 11371151 | Diarrhoea | |
113711514 | 11371151 | Disease progression | |
113711514 | 11371151 | Oral pain | |
113711514 | 11371151 | Pharyngeal disorder | |
113711514 | 11371151 | Renal cell carcinoma | |
113711514 | 11371151 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
113711514 | 11371151 | 1 | 201112 | 2013 | 0 |